Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Planel E, Bretteville A, Liu L, Virag L, Du AL, Yu WH, Dickson DW, Whittington RA, Duff KE.

FASEB J. 2009 Aug;23(8):2595-604. doi: 10.1096/fj.08-122424. Epub 2009 Mar 11.

2.

A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.

Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.

Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.

PMID:
18490011
3.

Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.

Leroy K, Ando K, Héraud C, Yilmaz Z, Authelet M, Boeynaems JM, Buée L, De Decker R, Brion JP.

J Alzheimers Dis. 2010;19(2):705-19. doi: 10.3233/JAD-2010-1276.

PMID:
20110614
4.

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.

Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, Yilmaz Z, Buée L, Brion JP.

Am J Pathol. 2007 Sep;171(3):976-92. Epub 2007 Aug 9.

5.

Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.

Ando K, Leroy K, Héraud C, Yilmaz Z, Authelet M, Suain V, De Decker R, Brion JP.

Am J Pathol. 2011 Feb;178(2):803-16. doi: 10.1016/j.ajpath.2010.10.034.

6.

mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.

Caccamo A, Magrì A, Medina DX, Wisely EV, López-Aranda MF, Silva AJ, Oddo S.

Aging Cell. 2013 Jun;12(3):370-80. doi: 10.1111/acel.12057. Epub 2013 Mar 24.

7.

IFN-γ promotes τ phosphorylation without affecting mature tangles.

Li A, Ceballos-Diaz C, DiNunno N, Levites Y, Cruz PE, Lewis J, Golde TE, Chakrabarty P.

FASEB J. 2015 Oct;29(10):4384-98. doi: 10.1096/fj.15-275834. Epub 2015 Jul 8.

8.

Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.

Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH.

Am J Pathol. 2003 Sep;163(3):1057-67.

9.

Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.

Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A.

Eur J Neurosci. 2011 May;33(9):1598-610. doi: 10.1111/j.1460-9568.2011.07660.x. Epub 2011 Apr 1.

10.

The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.

Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, Petrova O, Schönig K, Bujard H, Mandelkow E, Zhou L, Rune G, Mandelkow EM.

J Neurosci. 2008 Jan 16;28(3):737-48. doi: 10.1523/JNEUROSCI.2824-07.2008.

11.

High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.

Wheeler JM, McMillan PJ, Hawk M, Iba M, Robinson L, Xu GJ, Dombroski BA, Jeong D, Dichter MA, Juul H, Loomis E, Raskind M, Leverenz JB, Trojanowski JQ, Lee VM, Schellenberg GD, Kraemer BC.

Acta Neuropathol Commun. 2015 Jun 4;3:33. doi: 10.1186/s40478-015-0210-6.

12.

A seeding based cellular assay of tauopathy.

Xu Y, Martini-Stoica H, Zheng H.

Mol Neurodegener. 2016 Apr 26;11:32. doi: 10.1186/s13024-016-0100-9.

13.

A mouse model to study tau pathology related with tau phosphorylation and assembly.

Engel T, Lucas JJ, Hernández F, Avila J.

J Neurol Sci. 2007 Jun 15;257(1-2):250-4. Epub 2007 Mar 23.

PMID:
17362999
14.

Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM.

J Neurosci. 2013 Jan 16;33(3):1024-37. doi: 10.1523/JNEUROSCI.2642-12.2013.

15.

Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.

Spires-Jones TL, Friedman T, Pitstick R, Polydoro M, Roe A, Carlson GA, Hyman BT.

Neurosci Lett. 2014 Mar 6;562:63-8. doi: 10.1016/j.neulet.2014.01.013. Epub 2014 Jan 21.

16.

Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.

Koson P, Zilka N, Kovac A, Kovacech B, Korenova M, Filipcik P, Novak M.

Eur J Neurosci. 2008 Jul;28(2):239-46. doi: 10.1111/j.1460-9568.2008.06329.x.

PMID:
18702695
17.

Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).

Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH.

J Neurosci. 2005 Nov 16;25(46):10637-47.

18.

Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.

Seino Y, Kawarabayashi T, Wakasaya Y, Watanabe M, Takamura A, Yamamoto-Watanabe Y, Kurata T, Abe K, Ikeda M, Westaway D, Murakami T, Hyslop PS, Matsubara E, Shoji M.

J Neurosci Res. 2010 Dec;88(16):3547-54. doi: 10.1002/jnr.22516. Epub 2010 Oct 8.

PMID:
20936700
19.

Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.

Ando K, Kabova A, Stygelbout V, Leroy K, Heraud C, Frédérick C, Suain V, Yilmaz Z, Authelet M, Dedecker R, Potier MC, Duyckaerts C, Brion JP.

J Alzheimers Dis. 2014;40 Suppl 1:S135-45. doi: 10.3233/JAD-132237.

PMID:
24614899
20.

The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.

Matsumoto SE, Motoi Y, Ishiguro K, Tabira T, Kametani F, Hasegawa M, Hattori N.

Hum Mol Genet. 2015 Nov 15;24(22):6403-16. doi: 10.1093/hmg/ddv351. Epub 2015 Sep 15.

PMID:
26374846

Supplemental Content

Support Center